State Street Corp Acer Therapeutics Inc. Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.75 - $1.14 $1,417 - $2,154	-1,890 Reduced 3.44%	53,035 $48,000
Q4 2022 Feb 14, 2023	BUY	$1.13 - $4.15 $39,210 - $144,005	34,700 Added 171.57%	54,925 $137,000
Q3 2022 Nov 15, 2022	SELL	$1.28 - $1.6 $4,147 - $5,184	-3,240 Reduced 13.81%	20,225 $28,000
Q2 2022 Aug 15, 2022	SELL	$1.19 - $3.04 $2,499 - $6,384	-2,100 Reduced 8.21%	23,465 $30,000
Q1 2022 May 16, 2022	BUY	$1.98 - $2.98 $1,188 - $1,788	600 Added 2.4%	25,565 $74,000
Q2 2021 Aug 16, 2021	BUY	$2.52 - $3.18 $62,911 - $79,388	24,965 New	24,965 $71,000
Q4 2020 Feb 16, 2021	SELL	$2.34 - $2.99 $30,066 - $38,418	-12,849 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$2.16 - $5.41 $9,525 - $23,858	-4,410 Reduced 25.55%	12,849 $37,000
Q2 2020 Aug 14, 2020	SELL	$1.53 - $4.53 $182,798 - $541,226	-119,476 Reduced 87.38%	17,259 $59,000
Q1 2020 May 11, 2020	BUY	$1.18 - $5.86 $161,347 - $801,267	136,735 New	136,735 $272,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.